Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000025

Chief Medical Officer sold 3,366 shares at an average $30.03 ($101,071)

From the SEC's structured data for this filing

Trades in this filing

Ho Carole · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-10 Sale : show line 1 in the form −818 $29.80 $24,376 179,365 I
2023-02-13 Sale : show line 2 in the form −2,548 $30.10 $76,695 184,285 I
Open-market sales · 3,366 sh · avg $30.03 · $101,071
Loading xslF345X03/wf-form4_167641959398926.xml…